Literature DB >> 26890226

Current methods to diagnose small airway disease in patients with COPD.

Fernando Sergio Leitão Filho1, Hao Hang Chen1, David A Ngan1, Anthony Tam1, Miranda Kirby1, Don D Sin1.   

Abstract

The small airways are characterized by an internal diameter < 2 mm and absence of cartilage. Approximately 10-25% of total airway resistance in healthy lungs is due to the small airways, with their contribution to total airway resistance increasing substantially in chronic obstructive pulmonary disease (COPD). As the small airways are located in the lung periphery, they are not easily evaluable, which can potentially interfere with the diagnosis (especially at early stages), monitoring, detection of responses to clinical interventions, and prognostic evaluation in COPD. Here, we will discuss the currently available methods in clinical practice to evaluate small airway disease in COPD, focusing on the concept, advantages, and disadvantages of each method.

Entities:  

Keywords:  COPD; body plethysmography; computed tomography; small airways; spirometry; washout tests

Year:  2016        PMID: 26890226     DOI: 10.1586/17476348.2016.1155455

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  3 in total

1.  Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study.

Authors:  Xiaopei Yan; Li Xu; Baoyu Shi; Hui Wang; Xiao Xu; Guopeng Xu
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

Review 2.  Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review.

Authors:  Apeksha Koul; Rajesh K Bawa; Yogesh Kumar
Journal:  Arch Comput Methods Eng       Date:  2022-09-28       Impact factor: 8.171

3.  Quantitative Microbial Risk Assessment and Opportunist Waterborne Infections⁻Are There Too Many Gaps to Fill?

Authors:  Richard Bentham; Harriet Whiley
Journal:  Int J Environ Res Public Health       Date:  2018-06-01       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.